Literature DB >> 2458030

The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis.

S Bacus1, J L Flowers, M F Press, J W Bacus, K S McCarty.   

Abstract

A monoclonal antibody prepared against estrogen receptor has been shown to be specific and sensitive for the detection of estrogen receptor in human breast lesions by use of immunohistochemical methods. Two hundred selected cases of primary breast carcinoma were assayed for estrogen receptor content by biochemical and immunohistochemical procedures. Quantitative evaluation was by biochemical, immunohistochemical, and automated computer-assisted image analysis using the Cell Analysis System's CAS/100 machine (Lombard, IL). Quantitative estrogen receptor content was determined by dextran-coated charcoal analysis and sucrose density gradient analysis. Immunohistochemical evaluation incorporated both intensity and distribution of staining, yielding a subjective score, histologic score (HSCORE). An objective quantitation, also incorporating intensity and distribution of staining, was done by computer-assisted image analysis, quantitative immunocytochemical score (QIC SCORE). HSCORE analysis was done with and without methyl green counterstain with no loss of sensitivity. Comparison of QIC SCORE with the biochemical and immunohistochemical analysis of the tissues examined revealed excellent sensitivities and specificities. These data suggest that automated image analysis provides an effective qualitative and quantitative means of evaluating estrogen receptor content in human breast cancers.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458030     DOI: 10.1093/ajcp/90.3.233

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  28 in total

1.  Comparison of different detection methods in quantitative microdensitometry.

Authors:  L Ermert; A C Hocke; H R Duncker; W Seeger; M Ermert
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

2.  Asymmetric distribution of oncogene products at mitosis.

Authors:  B Czerniak; F Herz; R P Wersto; L G Koss
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

3.  Influence of the decrease of intracellular antigenic content on morphometric analysis: effect of the type and dilution of the first antibody.

Authors:  K Channaoui; J Rahier
Journal:  Histochemistry       Date:  1992

4.  Biological grading of breast cancer using antibodies to proliferating cells and other markers.

Authors:  S S Bacus; R Goldschmidt; D Chin; G Moran; D Weinberg; J W Bacus
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

5.  Integrated analysis of preclinical data to support the design of the first in man study of LY2181308, a second generation antisense oligonucleotide.

Authors:  Sophie Callies; Valérie André; Bharvin Patel; David Waters; Paul Francis; Michael Burgess; Michael Lahn
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

Review 6.  The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast.

Authors:  Zsolt Hodi; Jayeta Chakrabarti; Andrew H S Lee; John E Ronan; Christopher W Elston; Kwok Leung Cheung; John F R Robertson; Ian O Ellis
Journal:  J Clin Pathol       Date:  2006-05-26       Impact factor: 3.411

7.  Differential expression of VASP in normal lung tissue and lung adenocarcinomas.

Authors:  L Dertsiz; G Ozbilim; Y Kayisli; G A Gokhan; A Demircan; U A Kayisli
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

8.  Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis.

Authors:  G Garcia-Rostan; R L Camp; A Herrero; M L Carcangiu; D L Rimm; G Tallini
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

9.  Immunohistochemistry as an important tool in biomarkers detection and clinical practice.

Authors:  Leandro Luongo de Matos; Damila Cristina Trufelli; Maria Graciela Luongo de Matos; Maria Aparecida da Silva Pinhal
Journal:  Biomark Insights       Date:  2010-02-09

10.  Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.

Authors:  Nair Lopes; Bárbara Sousa; Diana Martins; Madalena Gomes; Daniella Vieira; Luiz A Veronese; Fernanda Milanezi; Joana Paredes; José L Costa; Fernando Schmitt
Journal:  BMC Cancer       Date:  2010-09-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.